494 related articles for article (PubMed ID: 11377240)
41. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
42. Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats.
Tyroller S; Zwickenpflug W; Thalheim C; Richter E
Toxicology; 2005 Nov; 215(3):245-53. PubMed ID: 16118032
[TBL] [Abstract][Full Text] [Related]
43. A comparative study of the mutagenicity of various types of tobacco products.
Rickert WS; Wright WG; Trivedi AH; Momin RA; Lauterbach JH
Regul Toxicol Pharmacol; 2007 Aug; 48(3):320-30. PubMed ID: 17614170
[TBL] [Abstract][Full Text] [Related]
44. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
Trushin N; Hecht SS
Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
[TBL] [Abstract][Full Text] [Related]
45. My career development with Ames test: A personal recollection.
Nohmi T
Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():503095. PubMed ID: 31699345
[TBL] [Abstract][Full Text] [Related]
46. Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108.
Kushida H; Fujita K; Suzuki A; Yamada M; Nohmi T; Kamataki T
Mutat Res; 2000 Nov; 471(1-2):135-43. PubMed ID: 11080669
[TBL] [Abstract][Full Text] [Related]
47. Mutagenicity studies on fenitrothion in bacteria and mammalian cells.
Hara M; Kogiso S; Yamada F; Kawamoto M; Yoshitake A; Miyamoto J
Mutat Res; 1989 Jan; 222(1):53-61. PubMed ID: 2643032
[TBL] [Abstract][Full Text] [Related]
48. Effects of different inducers of cytochrome P450 on the mutagenesis of the tobacco-specific nitrosamine 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK) in Salmonella typhimurium TA1535.
Teel RW
Anticancer Res; 1992; 12(4):1287-90. PubMed ID: 1503422
[TBL] [Abstract][Full Text] [Related]
49. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Environ Mol Mutagen; 2001; 38(4):339-46. PubMed ID: 11774366
[TBL] [Abstract][Full Text] [Related]
50. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
[TBL] [Abstract][Full Text] [Related]
51. Occupational exposure to unburnt bidi tobacco elevates mutagenic burden among tobacco processors.
Bagwe AN; Bhisey RA
Carcinogenesis; 1995 May; 16(5):1095-9. PubMed ID: 7767970
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of tobacco-specific N-nitrosamines and their metabolites and results of related bioassays.
Amin S; Desai D; Hecht SS; Hoffmann D
Crit Rev Toxicol; 1996; 26(2):139-47. PubMed ID: 8688157
[TBL] [Abstract][Full Text] [Related]
53. Mutagenic potential of Indian tobacco products.
Niphadkar MP; Bagwe AN; Bhisey RA
Mutagenesis; 1996 Mar; 11(2):151-4. PubMed ID: 8671731
[TBL] [Abstract][Full Text] [Related]
54. From cultivation to cancer: formation of
Stanfill SB; Hecht SS; Joerger AC; González PJ; Maia LB; Rivas MG; Moura JJG; Gupta AK; Le Brun NE; Crack JC; Hainaut P; Sparacino-Watkins C; Tyx RE; Pillai SD; Zaatari GS; Henley SJ; Blount BC; Watson CH; Kaina B; Mehrotra R
Crit Rev Toxicol; 2023 Nov; 53(10):658-701. PubMed ID: 38050998
[TBL] [Abstract][Full Text] [Related]
55. Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: A population-based study.
Pérez-Ortuño R; Martínez-Sánchez JM; Fu M; Ballbè M; Quirós N; Fernández E; Pascual JA
Environ Res; 2016 Nov; 151():635-641. PubMed ID: 27619208
[TBL] [Abstract][Full Text] [Related]
56. Mutagenicity of amine drugs and their products of nitrosation.
Andrews AW; Lijinsky W; Snyder SW
Mutat Res; 1984 Feb; 135(2):105-8. PubMed ID: 6363913
[TBL] [Abstract][Full Text] [Related]
57. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters.
Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M
Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534
[TBL] [Abstract][Full Text] [Related]
58. Examination of Alternaria alternata mutagenicity and effects of nitrosylation using the Ames Salmonella test.
Schrader TJ; Cherry W; Soper K; Langlois I; Vijay HM
Teratog Carcinog Mutagen; 2001; 21(4):261-74. PubMed ID: 11406832
[TBL] [Abstract][Full Text] [Related]
59. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
60. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
